Dr. Anne Violet Quismorio, MD

Dr. Quismorio practices at The Huntington Medical Foundation in Pasadena, California.

Dr. Quismorio's NPI, 1073740825, was assigned on June 19, 2009. Dr. Quismorio graduated from Keck School of Medicine of USC in 2007. Dr. Quismorio holds California license A108385.

Dr. Quismorio's primary practice is The Huntington Medical Foundation, at 55 E California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-8335.

Dr. Quismorio's primary practice is The Huntington Medical Foundation in Pasadena, California. Dr. Quismorio is also affiliated with Huntington Hospital. The medical group on file is Huntington Health Physicians. Dmand AI also links Dr. Quismorio to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quismorio practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Quismorio's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Quismorio is board certified in rheumatology by the American Board of Internal Medicine. Dr. Quismorio is licensed in California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Quismorio treats.

CMS data shows 1,965 Medicare services from Dr. Quismorio across 6 procedure codes in 2024, for 213 Medicare patients. Medicare paid $73,910 for them. Every service was in an office.

CMS counts 213 Medicare patients who saw Dr. Quismorio in 2024. The largest group is 75 to 84, with 85 patients. 75% of them have arthritis, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Quismorio's median patient age at 64, with 80% women.

In 2024, Dr. Quismorio wrote 1,436 Medicare Part D claims for 288 patients. 90% of them were for generic drugs. CMS names the drug for 1,297 of them, across 30 drugs with 11 or more claims each, at $216,767 in total drug cost. In 2023, CMS named 1,306 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Quismorio for performance year 2024, reported as part of a group. Dr. Quismorio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quismorio as offering telehealth.

Dmand AI links 3 papers to Dr. Quismorio in 2018. Dr. Quismorio's most frequent co-authors are Bhaumik Brahmbhatt, MBBS, Christina Lydia Chen, DO and Mindy S. Houng, MD.

CMS Open Payments shows 1,373 general payments to Dr. Quismorio from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Celgene Corporation paid the most, $67,785.

Dr. Quismorio graduated from Keck School of Medicine of USC in 2007.

Dr. Quismorio is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.